港股早評:三大指數高開 科技股普升 生物醫藥股持續活躍
隔夜美股止跌反彈,中概指數大升超3%。港股延續昨日反彈,恒指升0.22%,國指升0.27%,恒生科技指數升0.57%。盤面上,大型科技股普遍上升,京東升1.6%,百度升1.38%,阿里巴巴升1%,美團、騰訊飄紅,回港中概股新東方繼續大升13.7%;中金預期下半年醫藥行業將會有一定邊際改善,生物醫藥股持續活躍,來凱醫藥續升6%;“惡意降價”成往事,多地取消新房銷售限價,內房股普遍上升,直播概念股、餐飲股、食品飲料股多數上升。另一方面,香港本地銀行股走低,渣打銀行跌1.23%,中資券商股、濠賭股、汽車股、石油股部分下跌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.